adrenomedullin
功能和特点
有货
产品名称 | adrenomedullin |
---|
CAS编号和信息 | rp173386 |
---|
CAS Registry No. | 148498-78-6 |
---|---|
Entrez Gene | 133 |
Wikipedia | Adrenomedullin |
Ligand ID | 683 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
名称 | adrenomedullin | ||||||||||
类别 | Peptide | ||||||||||
学名 | 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide | ||||||||||
生物活性评价 |
The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in |
||||||||||
评价 | Adrenomedullin is 52 amino acid peptide which is mainly expressed in endothelial and smooth muscle cells. It acts as a vasodilatory peptide and it is known to regulate endothelial barrier function and vascular tone. Evidence from animal models indicates that it is a key player in the development of sepsis-associated hemodynamic and microcirculatory disorders. | ||||||||||
配体家族 | Neuropeptides | ||||||||||
基因/前体 |
|
||||||||||
单字母多肽序列 | YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY | ||||||||||
三字母多肽序列 | Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | ||||||||||
翻译后修饰 | The cysteine residues at positions 16 and 21 form a disulphide bridge and the C-terminal tyrosine is amidated. | ||||||||||
化学修饰 |
1. Struck J, Hein F, Karasch S, Bergmann A. (2013) Epitope specificity of anti-Adrenomedullin antibodies determines efficacy of mortality reduction in a cecal ligation and puncture mouse model.. Intensive Care Med Exp, 1 (1): (22). [PMID:26266791] |
2. Geven C, van Lier D, Blet A, Peelen R, Ten Elzen B, Mebazaa A, Kox M, Pickkers P. (2018) Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects.. Br J Clin Pharmacol, 84 (9): (2129-2141). [PMID:29856470] |
3. Geven C, Pickkers P. (2018) The mechanism of action of the adrenomedullin-binding antibody adrecizumab.. Crit Care, 22 (1): (159). [PMID:29895302] |